SYNGENE vs TAKE: Stock Comparison

SYNGENE INTERNATIONAL vs TAKEUpdated 22 Sept 26, 4:08 PM ISTNSE & company filings

SYNGENE INTERNATIONAL is the larger company by market capitalisation. SYNGENE INTERNATIONAL shows a higher dividend yield, faster revenue growth and a higher net margin, while TAKE shows a lower P/E, a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SYNGENE leads 6; TAKE leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SYNGENETAKE

Valuation lens

What price are you paying?

Market CapContext only
₹15,267 Cr
₹234 Cr
P/E RatioTAKE has the lower reading
68.89x
26.86x
P/B RatioSYNGENE has the lower reading
3.15x
11.13x
EPSTAKE has the higher reading
₹-0.05
₹0.07
Book ValueContext only
₹119.88
₹2.1
Dividend YieldSYNGENE has the higher reading
0.34%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SYNGENE is the larger company
₹15,267 Cr vs ₹234 Cr
P/E Ratio
TAKE has a lower P/E
26.86x vs 68.89x
P/B Ratio
SYNGENE has a lower P/B
3.15x vs 11.13x
EPS
TAKE has higher earnings per share
₹0.07 vs ₹-0.05
Dividend Yield
SYNGENE has a higher dividend yield
0.34% vs 0%
Revenue Growth (TTM YoY)
SYNGENE has faster revenue growth
1.8% vs 0%
EPS Growth (TTM YoY)
TAKE has faster EPS growth
0% vs -19.5%
Qtr Sales Growth
TAKE has stronger quarterly sales growth
153.77% vs -9.92%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSYNGENETAKE
SectorHealthcare
IndustryHealthcare Research Analytics & Technology

Price

MetricSYNGENETAKE
Live Price₹377.5₹15.84
Day Change-1.99%-3.83%
Volume4.22 L2.55 L
52-Week High₹678.95₹24.39
52-Week Low₹360.4₹10.11
Distance from 52W High-44.4%-35.06%

Valuation

MetricSYNGENETAKE
Market Cap₹15,267 Cr₹234 Cr
P/E Ratio68.89x26.86x
P/B Ratio3.15x11.13x
EPS₹-0.05₹0.07
Book Value₹119.88₹2.1
Dividend Yield0.34%0%

Growth

MetricSYNGENETAKE
Revenue Growth (TTM YoY)1.8%0%
EPS Growth (TTM YoY)-19.5%0%
Qtr Sales Growth-9.92%153.77%
Qtr Profit Growth76.67%9.73%

Profitability & Leverage

MetricSYNGENETAKE
ROE6.54%12.68%
ROCE7.51%14.44%
Net Margin11.26%0%
Operating Margin12.3%8.19%
Debt to Equity0x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSYNGENETAKE
Promoter Holding52.59% 0.09 pp0%
FII Holding11.82% 2.08 pp0.21% 0.08 pp
DII Holding28.02% 1.58 pp0%
Public Holding7.14% 0.45 pp99.79% 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SYNGENE INTERNATIONAL and TAKE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.